Bacterial host strain expressing recombinant DSBC

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9725516
APP PUB NO 20140141468A1
SERIAL NO

14131994

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a recombinant gram-negative bacterial cell comprising an expression vector comprising a recombinant polynucleotide encoding DsbC and one or more polynucleotides encoding an antibody or an antigen-binding fragment thereof specifically binding to CD154.

First Claim

See full text

Other Claims data not available

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UCB PHARMA S A1070 BRUSSELS

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ellis, Mark Slough, GB 46 389
Humphreys, David Paul Slough, GB 61 609

Cited Art Landscape

Load Citation

Patent Citation Ranking

  • 3 Citation Count
  • C12N Class
  • 53.39 % this patent is cited more than
  • 8 Age
Citation count rangeNumber of patents cited in rangeNumber of patents cited in various citation count ranges2925224021854181131251101 - 1011 - 2021 - 3031 - 4041 - 5051 - 6061 - 7071 - 8081 - 9091 - 100100 +0200400600800100012001400160018002000220024002600280030003200

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 8, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 8, 2029